<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499197</url>
  </required_header>
  <id_info>
    <org_study_id>Heart TIMING 001</org_study_id>
    <nct_id>NCT03499197</nct_id>
  </id_info>
  <brief_title>Heart TIMING - Heart Transplantation IMagING</brief_title>
  <official_title>Morphological and Functional Changes After Heart Transplantation - Role of Noninvasive Imaging in the Early Detection of Cardiac Allograft Rejection and Vasculopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research, Development and Innovation Fund of Hungary, Project no. NVKP_16-1-2016-0017</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The cardiac allograft rejection (CAR) and cardiac allograft vasculopathy (CAV) significantly
      affect the prognosis of patients after heart transplantation. The aim of the present study is
      to investigate and differentiate the adaptive and pathological cardiovascular changes after
      heart transplantation using different modalities. The investigator's main purpose is to
      define the role of the cardiovascular imaging methods and biomarkers in the early diagnosis
      of CAR and CAV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. 12-lead ECG - Resting standard 12-lead digital ECG will be recorded. Extended analysis
           will be performed according to the latest recommendations.

        2. Holter ECG - 24 hour Holter ECG will be recorded. Extended Holter ECG analysis will be
           performed.

        3. Life quality questionnaire, patient history - Detailed questionnaire about personal and
           family history, general symptoms and life quality.

        4. Laboratory biochemical examination - Besides the regular routine laboratory parameters,
           several specific parameters are planned to be measured, such as cardiac biomarkers.

        5. Endomyocardial biopsy

        6. Detailed transthoracic echocardiography including strain analysis and 3D measurement

        7. Detailed cardiac magnetic resonance (CMR) examination

        8. Coronary imaging - invasive coronarography and intravascular ultrasound (IVUS) and/or
           optical coherence tomography (OCT)

        9. Invasive pressure measurement - Measurement of coronary flow reserve (CFR) and
           microcirculation resistance index (IMR)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Anticipated">January 15, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Coronary allograft vasculopathy</measure>
    <time_frame>5 years</time_frame>
    <description>Coronary allograft vasculopathy confirmed based on IVUS/OCT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coronary allograft rejection</measure>
    <time_frame>5 years</time_frame>
    <description>Coronary allograft rejection confirmed based on endomyocardial biopsy/clinical parameters</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Transplant Failure and Rejection</condition>
  <condition>Magnetic Resonance Imaging</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>cardiac magnetic resonance imaging</intervention_name>
    <description>Detailed and regular CMR examination (LGE, stress perfusion, T1, T2 mapping)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent first cardiac transplantation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First heart transplantation

        Exclusion Criteria:

          -  Cardiogenic shock on/after day 28 after heart transplantation

          -  Lack of consent

          -  Lack of cooperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hajnalka Vago, MD, PhD</last_name>
    <phone>+3620 8258058</phone>
    <email>vagoha@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Heart and Vascular Center, Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hajnalka Vago, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>April 13, 2018</last_update_submitted>
  <last_update_submitted_qc>April 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University Heart and Vascular Center</investigator_affiliation>
    <investigator_full_name>Hajnalka Vágó MD PhD</investigator_full_name>
    <investigator_title>MD PhD, Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

